Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology | Nephrology/Urology

Liver Cancer

California

Duarte : City of Hope

A Treatment of Unresectable Hepatocellular Carcinoma with TheraSphere (Yittrium-90 Glass Microspheres): A HDE Treatment Use Protocol

Duarte : City of Hope

PHII-83 NCI #7792: A Phase II Trial of Dasatinib (BMS354825) in Advanced Hepatocellular Carcinoma

Duarte : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Los Angeles : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Los Angeles : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Delaware

Newark : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Florida

Miami : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Vero Beach : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Georgia

Atlanta : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Illinois

Chicago : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Chicago : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Peoria : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Indiana

South Bend : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Iowa

Iowa City : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Massachusetts

Boston : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Missouri

St. Louis : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

New Jersey

Hackensack : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

New York

Bronx : Biomedical Research Alliance of New York

Advanced Hepatocellular Carcinoma (Liver Cancer)

Buffalo : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

New York : Mount Sinai Medical Center

A Phase III randomized, placebo-controlled study of sorafenib in patients with advanced hepatocellular carcinoma

New York : Biomedical Research Alliance of New York

Advanced Hepatocellular Carcinoma (Liver Cancer)

New York : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

North Carolina

Durham : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Pennsylvania

Hershey : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Philadelphia : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Tennessee

Nashville : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Texas

Dallas : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Dallas : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Houston : S. R. Burzynski Clinic

Phase II Study Of Antineoplastons A10 In Patients With Primary Liver Cancer

Houston : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Wisconsin

Milwaukee : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

China

Beijing : Research Site:

A Study of Xeloda (Capecitabine) and PEGASYS in Treatment-Naive Patients With Advanced Liver Cancer

Hong Kong : Research Site:

A Study of Avastin (Bevacizumab) and TACE Treatment in Patients With Liver Cancer.

Hong Kong : Research Site:

A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer

France

Marseille : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Montpellier Cedex 5 : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Reims Cedex : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Rennes : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Villejuif : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Hong Kong

Kowloon : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Shatin : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Korea, Republic of

Gyeonggi-Do : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Seoul : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Seoul : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Seoul : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Kuala Lumpur

Cheras : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Negeri Sembilan

Nilai : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Philippines

Cebu City : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Davo City : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Manila : Research Site:

A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.

Quezon : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Singapore

Singapore : Research Site:

A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer

Singapore : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Singapore : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Taiwan

Kueishan : Research Site:

A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer

Kueishan : Research Site:

A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.

Tainan : Research Site:

A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.

Tainan : Research Site:

A Study of Xeloda (Capecitabine) and PEGASYS in Treatment-Naive Patients With Advanced Liver Cancer

Tainan : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Taipei : Research Site:

A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer

Taipei : Research Site:

A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.

Taipei : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Taipei City : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Thailand

Songkhla : Research Site:

A Study of Xeloda (Capecitabine) and PEGASYS in Treatment-Naive Patients With Advanced Liver Cancer

United Kingdom

Birmingham : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

London : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer

Northwood : Local Institution

Study of BMS-582664 or Doxorubicin in Locally Advanced or Metastatic Hepatocellular Cancer